Precision medicine for pediatric and adolescent acute leukemia

Bidragets beskrivning

The treatment of acute leukemia in children and adolescents is lenghty and causes a wide variety of short- and long-term adverse events. Moreover, despite intensive treatments, some patients experience a relapse. In this research project, we aim to elucidate the detailed mechanisms of acute leukemia by which the disease arises and resists therapies. Based on these findings, we seek novel precision therapies, especially for patients with a high risk for disease relapse. The research is being conducted together with many international collaborations and utilizes animal models of leukemia and drug screening settings in addition to cell culture models and patient samples.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering

Olli Lohi Orcid -palvelun logo
242 911 €

Finansiär

Finlands Akademi

Typ av finansiering

Kliniska forskare

Övriga uppgifter

Finansieringsbeslutets nummer

341540

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet

Identifierade teman

cancer